Cytochrome P450 inhibition profile in liver of veal calves administered a combination of 17β-estradiol, clenbuterol, and dexamethasone for growth-promoting purposes

被引:24
作者
Cantiello, Michela [1 ]
Carletti, Monica [1 ]
Dacasto, Mauro [2 ]
Martin, Pascal G. P. [3 ]
Pineau, Thierry [3 ]
Capolongo, Francesca [2 ]
Gardini, Giulia [1 ]
Nebbia, Carlo [1 ]
机构
[1] Univ Turin, Sez Farmacol & Tossicol, Dipartimento Patol Anim, I-10095 Grugliasco, TO, Italy
[2] Univ Padua, Sez Farmacol & Tossicol, Dipartimento Sanita Pubbl Patol Comparata & Igien, I-35100 Padua, Italy
[3] INRA, Lab Pharmacol Toxicol, F-31931 Toulouse, France
关键词
calves; liver; drug metabolism; inhibition; mRNA expression; growth-promoters;
D O I
10.1016/j.fct.2008.05.018
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
The effects of the administration of a combination of 17 beta-estradiol (10 mg i.m. for three times at 17 intervals), dexamethasone (4 mg/day for 6 days and 5 mg/day for further 6 days, dissolved in milk), clenbuterol (20 mu g/kg b.w./day, dissolved in milk, for the last 40 days before slaughtering) for promoting (GP) purposes on liver drug metabolising capacity were studied in crossbred Friesian calves. Compared to controls, liver preparations from GP-treated calves showed an overall reduction the extent of the ill vitro ability to metabolize testosterone and a number of substrates, most those associated with CYP 2C or CYP 3A, which also displayed a reduced expression on western By contrast the tested hydrolytic and conjugative pathways were not significantly affected. As by northern blot, the lack of significant differences in CYP mRNA abundance point to a post-transcriptional effect of the GP combination. The remarkable involvement of the affected hepatic CYPs in the transformation of both steroid hormones and a large array of commonly used drugs may result In further accumulation Of undesirable residues in meat and offals of illegally treated calves. (c) 2008 Elsevier Ltd. All rights
引用
收藏
页码:2849 / 2855
页数:7
相关论文
共 49 条
  • [1] Possible role of dexamethasone in sensitizing the beta-2-adrenergic receptor system in vivo in calves during concomitant treatment with clenbuterol
    Abraham, G
    Gottschalk, J
    Ungemach, FR
    [J]. PHARMACOLOGY, 2004, 72 (03) : 196 - 204
  • [2] Regulation of cytochrome P450 by posttranslational modification
    Aguiar, M
    Masse, R
    Gibbs, BF
    [J]. DRUG METABOLISM REVIEWS, 2005, 37 (02) : 379 - 404
  • [3] Clinical and pharmacological profile in a clenbuterol epidemic poisoning of contaminated beef meat in Italy
    Brambilla, G
    Cenci, T
    Franconi, F
    Galarini, R
    Macrì, A
    Rondoni, F
    Strozzi, M
    Loizzo, A
    [J]. TOXICOLOGY LETTERS, 2000, 114 (1-3) : 47 - 53
  • [4] Ex vivo formation of gastric metabolites of clenbuterol:: Preliminary characterisation of their chemical structure
    Brambilla, Gianfranco
    di Bez, Simone
    Pietraforte, Donatella
    Minetti, Maurizio
    Campanella, Luigi
    Loizzo, Alberto
    [J]. ANALYTICA CHIMICA ACTA, 2007, 586 (1-2) : 426 - 431
  • [5] Cytochrome P450 3A and their regulation
    Burk, O
    Wojnowski, L
    [J]. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2004, 369 (01) : 105 - 124
  • [6] BURKE MD, 1974, DRUG METAB DISPOS, V2, P583
  • [7] A HIGHLY SENSITIVE TOOL FOR THE ASSAY OF CYTOCHROME-P450 ENZYME-ACTIVITY IN RAT, DOG AND MAN - DIRECT FLUORESCENCE MONITORING OF THE DEETHYLATION OF 7-ETHOXY-4-TRIFLUOROMETHYLCOUMARIN
    BUTERS, JTM
    SCHILLER, CD
    CHOU, RC
    [J]. BIOCHEMICAL PHARMACOLOGY, 1993, 46 (09) : 1577 - 1584
  • [8] In vitro formation of metabolic-intermediate cytochrome P450 complexes in rabbit liver microsomes by tiamulin and various macrolides
    Carletti, M
    Gusson, F
    Zaghini, A
    Dacasto, M
    Marvasi, L
    Nebbia, C
    [J]. VETERINARY RESEARCH, 2003, 34 (04) : 405 - 411
  • [9] Protein kinases - the major drug targets of the twenty-first century?
    Cohen, P
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2002, 1 (04) : 309 - 315
  • [10] Recent developments in the use and abuse of growth promoters
    Courtheyn, D
    Le Bizec, B
    Brambilla, G
    De Brabander, HF
    Cobbaert, E
    de Wiele, AV
    Vercammen, J
    De Wasch, K
    [J]. ANALYTICA CHIMICA ACTA, 2002, 473 (1-2) : 71 - 82